Detecting and Diagnosing Atrial Fibrillation (D2AF): Study protocol for a cluster randomised controlled trial

Trials

Volumn 16, Issue 1, 2015, Pages

  Uittenbogaart, Steven B ^a   Verbiest van Gurp, Nicole ^b   Erkens, Petra M G ^b   Lucassen, Wim A M ^a   Knottnerus, J André ^b   Winkens, Bjorn ^b   van Weert, Henk C P M ^a   Stoffers, Henri E J H ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atrial fibrillation; Cardiovascular risk; Case finding; ECG; Elderly population; General practitioner; Primary care setting; Pulse palpation; Stroke

Indexed keywords

ARTICLE; ATRIAL FIBRILLATION; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPH; HOLTER MONITORING; HOME MONITORING; HUMAN; INCIDENCE; PALPATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; SPHYGMOMANOMETER; AGED; AMBULATORY ELECTROCARDIOGRAPHY; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; MALE; METHODOLOGY; MULTICENTER STUDY; NETHERLANDS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PROGNOSIS; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; TIME FACTOR;

AGED; ATRIAL FIBRILLATION; BLOOD PRESSURE DETERMINATION; CLINICAL PROTOCOLS; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; NETHERLANDS; PALPATION; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROGNOSIS; PULSE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SPHYGMOMANOMETERS; TIME FACTORS;

EID: 84945128502     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-1006-5     Document Type: Article

References (34)

1. Fitzmaurice D, Hobbs F, Jowett S. Screening for atrial fibrillation in older adults detects more cases than usual care. JCOM. 2007;14:11.
2. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006. doi: 10.1093/eurheartj/ehi825.
3. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010. doi: 10.1378/chest.09-1584.
4. Pisters R, van Oostenbrugge RJ, Knottnerus IL, de Vos CB, Boreas A, Lodder J, et al. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace. 2010. doi: 10.1093/europace/euq080.
5. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005. doi: 10.1161/01.STR.0000166053.83476.4a.
6. Rizos T, Wagner A, Jenetzky E, Ringleb PA, Becker R, Hacke W, et al. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis. 2011. doi: 10.1159/000330348.
7. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Int Med. 2007;146(12):857-67.
8. Lip GY, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res. 2006. doi: 10.1016/j.thromres.2005.08.007.
9. Sposato LA, Cipriano LE, Saposnik G, Vargas ER, Riccio PM, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2015. doi: 10.1016/S1474-4422(15)70027-X.
10. Lin HJ, Wolf PA, Benjamin EJ, Belanger AJ, D'Agostino RB. Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study Stroke. 1995;26(9):1527-30.
11. Hannon N, Sheehan O, Kelly L, Marnane M, Merwick A, Moore A, et al. Stroke associated with atrial fibrillation - incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis. 2010;29(1):43-9.
12. Frykman V, Frick M, Jensen-Urstad M, Ostergren J, Rosenqvist M. Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics. J Intern Med. 2001;250(5):390-7.
13. Vanassche T, Lauw MN, Eikelboom JW, Healey JS, Hart RG, Alings M. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J. 2015. doi: 10.1093/eurheartj/ehu307.
14. Laupacis A, Boysen G, Connolly S, Ezekowitz M, Hart R, James K, et al. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154(13):1449-57.
15. Fitzmaurice DA, Hobbs FDR, Jowett S, Mant J, Murray ET, Holder R et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. Brit Med J. 2007; doi: 10.1136/bmj.39280.660567.55.
16. Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? J R Coll Physicians Edinb. 2012;42 Suppl 18:5-22.
17. Willits I, Keltie K, Craig J, Sims A. WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension: guidance, MTG 13. Appl Health Econ Health Policy. 2014; doi: 10.1007/s40258-014-0096-7.
18. Tieleman RG, Plantinga Y, Rinkes D, Bartels GL, Posma JL, Cator R, et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace. 2014. doi: 10.1093/europace/euu057.
19. Hoefman E, van Weert HC, Boer KR, Reitsma J, Koster RW, Bindels PJ. Optimal duration of event recording for diagnosis of arrhythmias in patients with palpitations and light-headedness in the general practice. Fam Pract. 2007. doi: 10.1093/fampra/cml065.
20. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014. doi: 10.1056/NEJMoa1311376.
21. Quinn FR, Gladstone D. Screening for undiagnosed atrial fibrillation in the community. Curr Opin Cardiol. 2014; doi: 10.1097/hco.0000000000000018.
22. Hobbs FDR, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Asses. 2005;9(40):1-74.
23. Vaes B, Stalpaert S, Tavernier K, Thaels B, Lapeire D, Mullens W, et al. The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care. BMC Fam Pract. 2014;15:113.
24. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010. doi: 10.1093/europace/euq35.
25. Berg J, Lindgren P, Nieuwlaat R, Bouin O, Crijns H. Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. Qual Life Res. 2010. doi: 10.1007/s11136-010-9591-y.
26. van den Akker M, Metsemakers J, Limonard C, Knottnerus JA. General practice: a gold mine for research. Data and Scientific Use of the Registration Network Family Practices Maastricht. The Netherlands: Maastricht University; 2004.
27. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open source epidemiologic statistics for public health, version3.03. www.OpenEpi.com , updated 22 September 2014. Accessed 11 March 2015.
28. Kelsey JL. Methods in observational epidemiology. 2nd ed. New York: Oxford University Press; 1996.
29. Smeeth L, Ng ES. Intraclass correlation coefficients for cluster randomized trials in primary care: data from the MRC Trial of the Assessment and Management of Older People in the Community. Control Clin Trials. 2002;23(4):409-21.
30. Campbell MK, Thomson S, Ramsay CR, MacLennan GS, Grimshaw JM. Sample size calculator for cluster randomized trials. Comput Biol Med. 2004. doi: 10.1016/s0010-4825(03)00039-8.
31. Pepe MS. The statistical evaluation of medical tests for classification and prediction. Oxford statistical science series, vol 31. Oxford. New York: Oxford University Press; 2004.
32. Lowres N, Neubeck L, Redfern J, Freedman SB. Screening to identify unknown atrial fibrillation. Thromb Haemost: a systematic review; 2013. doi: 10.1160/TH13-02-0165.
33. Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation. 2013. doi: 10.1161/CIRCULATIONAHA.112.126656.
34. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart. 2001;86(3):284-8.